Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : TGL WHAAAAAAAT! Alerts, thoughts, discussion. -- Ignore unavailable to you. Want to Upgrade?

To: Taki who wrote (134589)	6/24/2004 10:34:32 AM
From: Bidder	Read Replies (1) \| Respond to of 150070

GFY Foods, Inc. Announces Launch of Corporate Web Site E-mail or Print this story 24 June 2004, 10:24am ET BUFFALO GROVE, Ill., June 24 /PRNewswire-FirstCall/ -- GFY Foods, Inc. (BB:GFYF) announced today that it has launched its new corporate web site gfyfoodsinc.com and will utilize this web site as the centerpiece of all of its advertising and marketing processes moving forward. "We've been so busy growing our business that we have not taken the time to focus on our online market presence -- but our new corporate web site is being launched as of today and we intend to utilize this site to communicate effectively with our customers, business partners and investors," said Ed Schwalb, President of GFY Foods, Inc. "We will add more dynamic features to the web site as we continue to grow -- our primary goal with this site initially is to provide people with a concise overview of our company and market focus and to provide them with one central source of information about our company." The company now has three active locations regionally. It has plans to grow nationally by rolling out additional locations in key market segments and to work closely with the Kahala Corporation to acquire new restaurants. It hopes to open 8-10 new locations by the end of calendar 2004, in metropolitan areas where there is minimal competition and significant upside to build a brand and establish the company nationally. About GFY Foods, Inc. Mentioned Last Change GFYF 0.0004 (Unchanged) Founded in the spring of 2003 by Ed Schwalb -- GFY Foods now has three franchise locations in place located in the Midwestern U.S. The company believes in the importance of providing high quality foods at affordable prices that are healthy alternatives to food that is now being sold to the American public. For more information please contact Ed Schwalb, President, 847.353.7554, 601 Deerfield Parkway, Buffalo Grove, IL 60089. ed@gfyfoodsinc.com . On the web: gfyfoodsinc.com . Investors and others are asked to no longer utilize the ares@bwwonline.com for e-mail contact, but to utilize the President's primary e-mail address, ed@gfyfoodsinc.com . This release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the company's current views with respect to future events that involve risks and uncertainties including uncertainties related to successful negotiations with other parties, closing of transactions, capital availability, operational and other risks, uncertainties and factors described from time to time in the company's publicly available SEC reports. In light of these risks and uncertainties, the forward-looking events described in this release might not occur. SOURCE GFY Foods, Inc. -0- 06/24/2004 /CONTACT: Ed Schwalb, President of GFY Foods, Inc., +1-847-353-7554, or ed@gfyfoodsinc.com / /Web site: gfyfoodsinc.com / (GFYF) CO: GFY Foods, Inc. ST: Illinois IN: FOD CPR MLM ADV SU: PDT HC -- NYTH081 -- 5637 06/24/2004 10:24 EDT prnewswire.com E-mail this story Print this story GFY Foods Inc (BB) News GFY Foods, Inc. Announces Launch of Corporate Web Site 24 June 2004, 10:24am ET, PR Newswire GFY Foods, Inc. Prepares to Launch Catering Division 27 May 2004, 10:41am ET, PR Newswire GFY Foods, Inc. Finalizes Acquisition of the Willowbrook Frullati Cafe and Bakery 13 May 2004, 10:00am ET, PR Newswire More GFYF News Free quote.com newsletters The Daily Quote Start your morning with a customized portfolio or hotlist and news. More » Portfolio Mailers Get your portfolio, or hotlist with customized news headlines, mailed to you at the end of the day. Setup a portfolio first » -------------------------------------------------------------------------------- About Quote.com, our redesign, accessibility features and access key information. » Lycos Worldwide © Copyright 2004, Lycos, Inc. All Rights Reserved. Lycos® is a registered trademark of Carnegie Mellon University. About Terra Lycos \| Help \| Jobs \| Advertise \| Business Development Your use of this website constitutes acceptance of the

To: Taki who wrote (134589)	6/24/2004 10:54:23 AM
From: SSP	Read Replies (1) \| Respond to of 150070

Bamm Bamm - cnews.canoe.ca

To: Taki who wrote (134589)	6/24/2004 12:04:10 PM
From: dkgross	Read Replies (2) \| Respond to of 150070

TFCT...amazing that it's not running on the news.

To: Taki who wrote (134589)	6/24/2004 5:52:21 PM
From: StocksDATsoar	Respond to of 150070

LOOK,IT'S A BABY TAKI LOLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLL cnews.canoe.ca Super baby holds cures? By LINDA A. JOHNSON A seven-month old baby with a genetic mutation that boosts muscle growth is seen in an undated black and white image released by the New England Journal of Medicine. (AP Photo/New England Journal of Medicine, HO) (AP) - Somewhere in Germany is a baby Superman, born in Berlin with bulging arm and leg muscles. Not yet 5, he can hold seven-pound weights with arms extended, something many adults cannot do. He has muscles twice the size of other kids his age and half their body fat. DNA testing showed why: The boy has a genetic mutation that boosts muscle growth. The discovery, reported in Thursday's New England Journal of Medicine, represents the first documented human case of such a mutation. Many scientists believe the find could eventually lead to drugs for treating people with muscular dystrophy and other muscle-destroying conditions. And athletes would almost surely want to get their hands on such a drug and use it like steroids to bulk up. Drugmaker Wyeth, based in Madison, N.J., already has begun human tests of a genetically engineered drug designed to bind to and neutralize myostatin, said spokeswoman Natalie de Vane. The boy's mutant DNA segment was found to block production of a protein called myostatin that limits muscle growth. The news comes seven years after researchers at Johns Hopkins University in Baltimore created buff "mighty mice" by "turning off" the gene that directs cells to produce myostatin. "Now we can say that myostatin acts the same way in humans as in animals," said the boy's physician, Dr. Markus Schuelke, a professor in the child neurology department at Charite/University Medical Center Berlin. "We can apply that knowledge to humans, including trial therapies for muscular dystrophy." Given the huge potential market for such drugs, researchers at universities and pharmaceutical companies already are trying to find a way to limit the amount and activity of myostatin in the body. At Wyeth, de Vane said the company's first clinical trials of its antibody-based drug targeting the myostatin protein are testing whether it is effective against muscular dystrophy or sarcopenia, the loss of muscle mass and strength due to aging and diseases including cancer. The drug is known only as MYO-029 at this point. The company is not yet projecting when results will be available. Dr. Lou Kunkel, director of the genomics program at Boston Children's Hospital and professor of pediatrics and genetics at Harvard Medical School, said success is possible within several years. "Just decreasing this protein by 20, 30, 50 percent can have a profound effect on muscle bulk," said Kunkel, who is among the doctors participating in the Wyeth research. Muscular dystrophy is the world's most common genetic disease. There is no cure and the most common form, Duchenne's, usually kills before adulthood. The few treatments being tried to slow its progression have serious side effects. Muscle wasting also is common in the elderly and patients with diseases such as cancer and AIDS. "If you could find a way to block myostatin activity, you might slow the wasting process," said Dr. Se-Jin Lee, the Johns Hopkins professor whose team created the "mighty mice." Lee said he believes a myostatin blocker also could suppress fat accumulation and thus thwart the development of diabetes. Lee and Johns Hopkins would receive royalties for any myostatin-blocking drug made by Wyeth. Dr. Eric Hoffman, director of Children's National Medical Center's Research Center for Genetic Medicine, said he believes a muscular dystrophy cure will be found, but he is unsure whether it will be a myostatin-blocking drug, another treatment or a combination, because about a dozen genes have some effect on muscles. He said a mystotatin-blocking drug could help other groups of people, including astronauts and others who lose muscle mass during long stints in zero gravity or when immobilized by illness or a broken limb. Researchers would not disclose the German boy's identity but said he was born to a somewhat muscular mother, a 24-year-old former professional sprinter. Her brother and three other close male relatives all were unusually strong, with one of them a construction worker able to unload heavy curbstones by hand. In the mother, one copy of the gene is mutated and the other is normal; the boy has two mutated copies. One almost definitely came from his father, but no information about him has been disclosed. The mutation is very rare in people. The boy is healthy now, but doctors worry he could eventually suffer heart or other health problems. In the past few years, scientists have seen great potential in myostatin-blocking strategies. Internet marketers have been hawking "myostatin-blocking" supplements to bodybuilders, though doctors say the products are useless and perhaps dangerous. Some researchers are trying to turn off the myostatin gene in chickens to produce more meat per bird. And several breeds of cattle have natural variations in the gene that, aided by selective breeding, give them far more muscle and less fat than other steer.